NCT04988672招募中不适用
OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 4,000
- 试验地点
- 1
- 主要终点
- Rate of major adverse cardiac and cerebrovascular events (MACCE) (including new AMI, stroke or cardiovascular death) at 1 year
研究概览
简要总结
The purpose of the OPTIMISER Registry is to prospectively and retrospectively collect baseline, clinical and procedural data in patients who present with AMI and are treated with PCI as well as prospectively collect the clinical outcome data. Outcomes will be compared in different clinical subgroups. The impact of PCI in AMI in general as well as cardiovascular outcomes after AMI will be assessed.
详细描述
- To assess procedural success and clinical outcomes among persons with AMI, who undergo PCI and/ or CABG for AMI (STEMI or NSTEMI)
- Periprocedural outcomes/ complications, which will be analyzed, represent: final result (e.g. TIMI flow), stent expansion, dissections, perforations, prevalence of thrombus (assessed by angiography and intravascular imaging)
- Short and long-term clinical outcomes of interest including: new AMI, unstable angina (UA), stent-/scaffold thrombosis, target lesion failure, target vessel revascularization, ischemia driven revascularization, repeat hospitalization, new/worsening heart failure, cardiogenic shock, stroke, bleedings, cardiovascular death and all-cause death.
- To describe procedural and clinical performance of various balloon, stent and scaffold devices implanted in patients presenting with AMI during the afore mentioned period
- To study the impact of different devices and strategies used for lesion preparation and PCI optimization strategies among patients undergoing PCI
- To describe early and late angiographic and OCT-findings among coronary artery disease in patients with AMI treated with various metallic stent and scaffold devices
- To assess possible predictors for coronary stent implantation or device failure
- To evaluate the impact of different antithrombotic regimens on patient clinical outcomes
- To study procedural and clinical outcomes among CAD patients requiring hemodynamic support using mechanical devices.
- To describe economic implications (cost-effectiveness) of various interventional treatments for CAD.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject >18 years of age
- •Individuals who are newly diagnosed with AMI or have been diagnosed with AMI (STEMI or NSTEMI) within the last 5 years (since 2016).
- •Subjects must be willing to sign a patient informed consent (PIC) OR a patient ́s relative/ proxy are willing to provide PIC or patients have signed the General Consent (GK).
排除标准
- •Patient unwilling or unable to provide informed consent
- •Patients with no ACS/AMI (e.g. Takotsubo cardiomyopathy, acute heart failure not related to AMI)
结局指标
主要结局
Rate of major adverse cardiac and cerebrovascular events (MACCE) (including new AMI, stroke or cardiovascular death) at 1 year
时间窗: at 1 year
次要结局
- Rate of acute renal failure(1, 2, 5 and 10 years)
- Rate of new ventricular arrhythmias(1, 2, 5 and 10 years)
- Rate of target lesion failure(1, 2, 5 and 10 years)
- Rate of major adverse cardiac and cerebrovascular events (MACCE)(1, 2, 5 and 10 years)
- Rate of stent thrombosis(1, 2, 5 and 10 years)
- Rate of cardiovascular mortality(1, 2, 5 and 10 years)
- Rate of all-cause mortality(1, 2, 5 and 10 years)
- Rate of cardiogenic shock(1, 2, 5 and 10 years)
- Rate of new atrial fibrillation(1, 2, 5 and 10 years)
- Rate of major adverse limb events (MALE)(1, 2, 5 and 10 years)
- Rate of ischemia-driven revascularization(1, 2, 5 and 10 years)
- Rate of new York Heart Association (NYHA) class(1, 2, 5 and 10 years)
- Rate of new AMI(1, 2, 5 and 10 years)
- Rate of TIA or stroke(1, 2, 5 and 10 years)
- Rate of target vessel revascularization(1, 2, 5 and 10 years)
- Rate of unstable angina(1, 2, 5 and 10 years)
- Rate of rehospitalisation for heart failure, resuscitated cardiac arrest or implantable cardioverter-defibrillator (ICD) implantation at follow- up.(1, 2, 5 and 10 years)
- Rate of rehospitalization for recurrent angina(1, 2, 5 and 10 years)
- Rate of periprocedural complications (e.g. coronary perforations, no- reflow)(1, 2, 5 and 10 years)
- Rate of hospitalization for heart failure(1, 2, 5 and 10 years)
- Rate of bleeding events (access site or non-access site related) according to the BARC classification.(1, 2, 5 and 10 years)
- Rate of vascular complications (according to VARC criteria)(1, 2, 5 and 10 years)
研究者
Matthias Bossard
Co-principal Investigator
Luzerner Kantonsspital
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaEuvolemic HyponatremiaHypervolemic HyponatremiaNCT01240668Otsuka America Pharmaceutical5,028
招募中
不适用
Ion Therapy Patient RegistryIon Beam Radiation Therapy for Tumor PatientsNCT03049072EBG MedAustron GmbH2,800
招募中
不适用
SIROOP Registry - a Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated with SIROlimus or Paclitaxel Eluting Balloon CathetersCoronary DiseaseCoronary RestenosisCoronary ArteriosclerosisCoronary Artery CalcificationStable Chronic AnginaAngina, StableAngina, UnstableStent ThrombosisCoronary Artery DiseaseAngina PectorisNCT04988685Luzerner Kantonsspital2,000
Unknown
不适用
Registry Evaluating AF Ablation TechniquesCatheter AblationAtrial FibrillationNCT03695484Erasmus Medical Center212
已完成
不适用
A Study of Patients With HER2-Positive Metastatic Breast CancerBreast CancerNCT00105456Genentech, Inc.1,000